ABMD Financial Facts

Funded research and development: 6K
Provision for income taxes: 6.29M
See Full Income Statement

Cash and cash equivalents: 22.4M
Total current liabilities: 39.32M
See Full Balance Sheet

Abiomed Inc. (ABMD) Earnings

  |   Expand Research on ABMD
Next EPS Date 10/30/15 *Est. EPS Growth Rate +600.0% *Last Qtr.
Average EPS % Beat Rate +587.5% Revenue Growth Rate +50.4% *Last Qtr.
Average % Move 1-Wk after EPS +21.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/4/15 Q116 $0.20$0.08 +$0.12$73.4M$66.27M N/A Details
5/5/15 Q415 $2.24$0.14 +$2.10$67.6M$62.55M N/A Details
1/28/15 Q315 $0.30$0.04 +$0.26$62M$53.2M Details
10/30/14 Q215 $0.03$0.02 +$0.01$51.8M$48.8M Details
7/31/14 Q115 -$0.04N/A N/A $48.8M$297.1M Details
5/1/14 Q414 $0.09$0.08 +$0.01$50.4M$50.93M Details
1/30/14 Q314 $0.11$0.05 +$0.06$46.2M$46M Details
11/6/13 Q214 $0.03$0.00 +$0.03$44.3M$43.75M Details